| Previous close | 62.94 |
| Open | 63.00 |
| Bid | 52.71 x 40000 |
| Ask | 54.00 x 70000 |
| Day's range | 62.88 - 63.46 |
| 52-week range | 54.37 - 68.43 |
| Volume | 202,016 |
| Avg. volume | 634,552 |
| Market cap | 10.86B |
| Beta | 0.72 |
| PE ratio (TTM) | 16.20 |
| EPS (TTM) | 3.88 |
| Earnings date | 1 Aug 2017 |
| Dividend & yield | 0.00 (0.00%) |
| Ex-dividend date | 2016-08-04 |
| 1y target est | 69.81 |
- GlobeNewswire•8 days ago
Amyris Enters Into First Product Development and Production Agreement With Royal DSM For Food and Nutrition Molecule
EMERYVILLE, Calif., July 17, 2017-- Amyris, Inc., the industrial bioscience company, today announces that it has entered into its first product development and production agreement with Koninklijke DSM ...
- PR Newswire•11 days ago
DSM Finalizes Repurchase of Shares to Cover Existing Option Plans and Stock Dividends
HEERLEN, Netherlands , July 14, 2017 /PRNewswire/ -- Royal DSM, a global science-based company active in health, nutrition and materials , has repurchased 2 61 , 898 of it s own shares in the period from ...
- PR Newswire•18 days ago
DSM - Repurchase of Shares (30 June - 6 July 2017)
HEERLEN, Netherlands , July 7, 2017 /PRNewswire/ -- Royal DSM, a global science-based company active in health, nutrition and materials , has repurchased 218,403 of it s own shares in the period from 3 ...
